InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Day Lucy. Insider active across 1 company, notably AN2 Therapeutics, Inc.. In total, 6 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €7k. History available since 15 March 2024. The latest transaction was filed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Day Lucy is a declarant linked to AN2 Therapeutics, Inc., where the listed role is Chief Financial Officer. The 4 filings on record, over the period from 2024-03-18 to 2025-02-28, show sales of EUR 3862 and no purchases, with the dominant transaction nature listed as Attribution.